Journal of Medicinal Chemistry p. 1386 - 1396 (1995)
Update date:2022-08-11
Topics:
Burke Jr.
Barchi Jr.
George
Wolf
Shoelson
Yan
Inhibitors of specific src homology 2 (SH2) domain binding interactions could potentially afford new therapeutic approaches toward a variety of diseases, including several cancers. To date SH2 domain inhibitors have been confined to small phosphotyrosyl (
View More
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Shanghai WinTide BioTechnology Co.,Ltd
Contact:86-21-37100630
Address:No. 908 Yunhe Road, Fengxian district, Shanghai
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376，63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
qingdao goldenchem imp and exp co.,ltd.
Contact:532-55579246
Address:no.62 ,haier road laoshan distirct
SHANDONG ZHANHUA YONGHAO PHARMACEUTICAL TECH.CO.,LTD
Contact:+86-576-88685096
Address:GENGJU VILLAGE NORTH ONE KILOMETER,ZHANHUA DISTRICT,BINZHOU CITY,SHANDONG PROVINCE,CHINA.
Doi:10.1002/anie.200704856
(2008)Doi:10.1016/j.jcat.2013.07.021
(2013)Doi:10.1002/ejic.201402736
(2014)Doi:10.1016/j.tetlet.2009.07.006
(2009)Doi:10.1021/acs.orglett.9b00043
(2019)Doi:10.1007/BF01418607
(1936)
